Loading clinical trials...
Loading clinical trials...
A Phase II Study Using the CliniMACS® Device for CD34+ Cell Selection and T Cell Depletion for Graft-versus-Host Disease Prophylaxis in Alternative Donor Stem Cell Transplant Recipients
Conditions
Interventions
CliniMACS® (T cell depletion)
Locations
1
United States
Levine Children's Hospital, Carolinas Medical Center
Charlotte, North Carolina, United States
Start Date
August 1, 2009
Primary Completion Date
November 1, 2016
Completion Date
November 1, 2016
Last Updated
April 22, 2022
NCT06735690
NCT05564390
NCT03050268
NCT06074666
NCT07320235
NCT06514534
Lead Sponsor
Wake Forest University Health Sciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions